methyl 7-(2-trimethylsilyl-ethoxymethoxy)-naphthalene-2-carboxylate | 188861-94-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: methyl 7-(2-trimethylsilyl-ethoxymethoxy)-naphthalene-2-carboxylate
• 英文别名: Methyl 7-(2-trimethylsilylethoxymethoxy)naphthalene-2-carboxylate
• CAS: 188861-94-1
• 化学式: C₁₈H₂₄O₄Si
• 分子量: 332.472
• InChiKey: RNZWRMPZWONDRK-UHFFFAOYSA-N

物化性质

• 沸点：
  429.8±30.0 °C(Predicted)
• 密度：
  1.072±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.32
• 重原子数：
  23
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 7-(2-trimethylsilyl-ethoxymethoxy)-naphthalene-2-carboxylate 在 四氯化碳 、 lithium aluminium tetrahydride 、 三苯基膦 作用下， 以 乙醚 、 乙腈 为溶剂， 反应 1.0h， 生成 2-chloromethyl-7-(β-trimethyl-silylethoxymethoxy)-naphthalene
  参考文献：
  名称：

  Piperidine-renin inhibitors compounds with improved physicochemical properties

  摘要：

  Piperidine renin inhibitors with heterocyclic core modifications or hydrophilic attachments show improved physical properties (lower lipophilicity, improved solubility). Tetrahydroquinoline derivative rac-30 with a molecular weight of 517 and a log D(pH 7.4) of 1.9 displays potent and long lasting blood pressure lowering effects after oral administration to sodium depleted conscious marmosets. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00196-1
• 作为产物：
  描述：

  methyl 7-methoxy-2-naphthoate 在 甲醇 、 三溴化硼 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 11.0h， 生成 methyl 7-(2-trimethylsilyl-ethoxymethoxy)-naphthalene-2-carboxylate
  参考文献：
  名称：

  Piperidine-renin inhibitors compounds with improved physicochemical properties

  摘要：

  Piperidine renin inhibitors with heterocyclic core modifications or hydrophilic attachments show improved physical properties (lower lipophilicity, improved solubility). Tetrahydroquinoline derivative rac-30 with a molecular weight of 517 and a log D(pH 7.4) of 1.9 displays potent and long lasting blood pressure lowering effects after oral administration to sodium depleted conscious marmosets. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00196-1

文献信息

• Piperidine derivatives having renin inhibiting activity
  申请人：Hoffmann-La Roche Inc.

  公开号：US06051712A1

  公开（公告）日：2000-04-18

  Novel piperidine derivatives, their manufacture and use as medicaments, are disclosed. The invention is concerned with the novel piperidine derivatives of general formula I ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, Q, X, Z, m and n are as described herein.

  揭示了一种新的哌啶衍生物的制备和用途作为药物。该发明涉及一般式I的新的哌啶衍生物 ##STR1## 其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、Q、X、Z、m和n如本文所述。
• Piperidine-renin inhibitors compounds with improved physicochemical properties
  作者：Rolf Güller、Alfred Binggeli、Volker Breu、Daniel Bur、Walter Fischli、Georges Hirth、Christian Jenny、Manfred Kansy、François Montavon、Marcel Müller、Christian Oefner、Heinz Stadler、Eric Vieira、Maurice Wilhelm、Wolfgang Wostl、Hans Peter Märki

  DOI：10.1016/s0960-894x(99)00196-1

  日期：1999.5

  Piperidine renin inhibitors with heterocyclic core modifications or hydrophilic attachments show improved physical properties (lower lipophilicity, improved solubility). Tetrahydroquinoline derivative rac-30 with a molecular weight of 517 and a log D(pH 7.4) of 1.9 displays potent and long lasting blood pressure lowering effects after oral administration to sodium depleted conscious marmosets. (C) 1999 Elsevier Science Ltd. All rights reserved.